StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)

Equities research analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Tuesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR stock opened at $0.47 on Tuesday. The firm has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.76. Avinger has a 12 month low of $0.36 and a 12 month high of $4.37. The firm has a market capitalization of $1.57 million, a PE ratio of -0.04 and a beta of 1.09.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.